Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2021-10-18 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of duplicate share certificates due to lost or misplaced original certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to share certificate management. The content is about share certificate replacement, not about financial results, management changes, or other report types. It is a notification related to share capital but specifically about duplicate share certificates, which aligns with announcements about share capital changes or share issues. Given the nature of the document, it fits best under 'Share Issue/Capital Change' (SHA) category rather than other categories like Regulatory Filings or Director's Dealing. The document is short and does not contain financial data or report attachments, so it is not a report or report announcement.
2021-10-18 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates ....
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of duplicate share certificates due to lost or misplaced original certificates. It references SEBI Listing Obligations and Disclosure Requirements, Regulation 39(3), which pertains to share certificate matters. The content is about notifying the exchanges of a share certificate issue, not about financial results, management changes, or other report types. The document length is short (1294 characters), and it is an official notification about share certificates. This fits the category of Share Issue/Capital Change (SHA), as it involves changes in share certificates and capital records.
2021-10-18 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice dated 13th October 2021 addressed to stock exchanges informing about a forthcoming Board of Directors meeting scheduled for 26th October 2021. The purpose of the meeting is to consider the unaudited financial results for the quarter and nine months ended 30th September 2021. The document is brief (1020 characters) and serves as an announcement of an upcoming event rather than containing any financial data or results itself. It references the SEBI Listing Obligations and Disclosure Requirements, indicating a regulatory compliance announcement. Given the short length and nature of the content, this is not the financial report itself but a notification about the meeting where such results will be considered. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement rather than an Interim Report (IR) or Earnings Release (ER).
2021-10-13 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, provided by the Registrar and Share Transfer Agent (RTA) for the quarter ended 30th September 2021. It confirms the processing of dematerialisation requests and compliance with SEBI circulars. The document is a formal attestation or certification letter rather than a full financial report or detailed regulatory filing. It does not contain financial statements or substantive financial data but serves as a compliance certificate submitted to stock exchanges. According to the Certification Rule, such officer certifications or confirmation letters should be classified as Regulatory Filings (RNS). The document length is short (3087 characters), and it is not an announcement of a report but the certificate itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-10-13 English
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board of Directors meeting scheduled for 26th October 2021. The purpose of the meeting is to consider unaudited financial results for the quarter and nine months ended 30th September 2021. The document is brief (1020 characters) and does not contain any actual financial data or detailed results. It is an announcement of a future event related to financial reporting, not the report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement under SEBI regulations.
2021-10-13 English
Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the quarter ended 30th September 2021 under Regulation ....
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, provided by the Registrar and Share Transfer Agent (RTA) for the quarter ended 30th September 2021. It confirms the processing of dematerialisation requests and compliance with SEBI circulars regarding timelines. The document is a formal attestation or certification letter addressed to stock exchanges, not a financial report or detailed filing. It does not contain financial statements or substantive financial data but serves as a regulatory compliance certificate. According to the Certification Rule, such officer certifications or confirmations should be classified as Regulatory Filings (RNS). The document length is short (3087 characters), and it is not an announcement of a report but the certificate itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-10-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.